This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Self-Management

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Using Vitamin C Plus Insulin to Stop Diabetes Damage

Posted: Wednesday, June 24, 2009

Researchers have found a way to stop the damage caused by Type 1 diabetes with the combination of insulin and a common vitamin found in most medicine cabinets. This simply means that getting your glucose under control is not enough.

Rosiglitazone Plus Metformin Prevents Bone Loss

Posted: Wednesday, June 24, 2009

Recent research shows that rosiglitazone decreases bone mineral density in healthy humans and appears to increase fractures in women with Type 2 diabetes, compared with those receiving metformin or another diabetes medication.

New Evidence Links Glitazones to Broken Bones

Posted: Wednesday, June 24, 2009

The largest study to date looking at whether the risk of bone fractures is increased in the setting of thiazolidinedione drugs (TZDs) suggests that fracture risk is more than 40% higher in people taking TZDs and that both men and women are vulnerable.

The Versatile Benefits of Red Wine and Component Resveratrol

Posted: Thursday, June 18, 2009

Moderate red wine consumption is known to have many benefits, including protection against heart disease, diabetes and neurodegenerative conditions, and is believed to be the ultimate answer to the “French paradox.” Red wine is a complex chemical mix, with many of its constituents believed to benefit the human body in some form. Polyphenols, especially resveratrol, are believed to be a particularly important component of red wine when considering health benefits, and a recent review has displayed the far-reaching potential for these compounds.

Once-Weekly Exenatide Provides Glycemic Control and Weight Loss

Posted: Wednesday, June 17, 2009

Once-weekly exenatide (EQW) produces superior improvements in glucose control and body weight compared with maximum daily doses of sitagliptin and pioglitazone on background metformin, according to study results presented at the ADA 69th Scientific Sessions.

Inhaled Insulin AFRESA(R) Controls Post-Meal Sugar Levels with Less Weight Gain and Hypoglycemia

Posted: Wednesday, June 17, 2009

The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA® (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia for adult patients with diabetes.

Liraglutide Reverses Prediabetes 90%

Posted: Wednesday, June 17, 2009

Researchers at the ADA reported that Liraglutide reverses prediabetes indices in most obese patients with existing prediabetes.

GLP-1 Liraglutide Versus Sulfonylureas

Posted: Wednesday, June 17, 2009

Novo Nordisk experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a clinical trial.

Meditative Yoga Effective Treatment for Insomnia

Posted: Sunday, June 14, 2009

Irregular and insufficient sleeping schedules have been linked to numerous health concerns, such as obesity, heart disease, diabetes and dementia. A recent study has concluded that practicing daytime deep relaxation techniques, namely meditation, greatly helps limit incidence of insomnia, potentially helping decrease risk of developing these above conditions.

Vitamin C Helps Protect Against Type 1 Diabetes Damage

Posted: Friday, June 12, 2009

Poor blood glucose control can lead to blood vessel and nerve cell damage in diabetics, and the only known way to prevent this is to maintain healthy blood glucose levels, and even this doesn’t always work. A recent research team, however, has found that combining insulin with vitamin C stops blood vessel damage in type 1 diabetics.